4-异硫代氰酰基联苯 | 1510-24-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-异硫代氰酰基联苯
• 英文名称: 1-isothiocyanato-4-phenylbenzene
• 英文别名: 4-isothiocyanato-1,1'-biphenyl；4-biphenyl isothiocyanate；4-isothiocyanatobiphenyl；p-Biphenylyl-isothiocyanat；Biphenylyl-(4)-isothiocyanat
• CAS: 1510-24-3
• 化学式: C₁₃H₉NS
• 分子量: 211.287
• InChiKey: WPYSJFXXQNITBC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  44.4
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2930909090

反应信息

• 作为反应物：
  描述：

  4-异硫代氰酰基联苯 在 ammonium hydroxide 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 生成 (4-苯基苯基)硫脲
  参考文献：
  名称：

  Design, Synthesis, X-ray Crystallographic Analysis, and Biological Evaluation of Thiazole Derivatives as Potent and Selective Inhibitors of Human Dihydroorotate Dehydrogenase

  摘要：

  Human dihydroorotate dehydrogenase (HsDHODH) is a flavin-dependent mitochondrial enzyme that has been certified as a potential therapeutic target for the treatment of rheumatoid arthritis and other autoimmune diseases. On the basis of lead compound 4, which was previously identified as potential HsDHODH inhibitor, a novel series of thiazole derivatives were designed and synthesized. The X-ray complex structures of the promising analogues 12 and 33 confirmed that these inhibitors bind at the putative ubiquinone binding tunnel and guided us to explore more potent inhibitors, such as compounds 44, 46, and 47 which showed double digit nanomolar activities of 26, 18, and 29 nM, respectively. Moreover, 44 presented considerable anti-inflammation effect in vivo and significantly alleviated foot swelling in a dose-dependent manner, which disclosed that thiazole-scaffold analogues can be developed into the drug candidates for the treatment of rheumatoid arthritis by suppressing the bioactivity of HsDHODH.

  DOI：

  10.1021/jm501127s
• 作为产物：
  描述：

  (4-苯基苯基)硫脲 在 乙酸酐 作用下， 生成 4-异硫代氰酰基联苯
  参考文献：
  名称：

  Brewster; Horner, Transactions of the Kansas Academy of Science, 1937, vol. 40, p. 101

  摘要：

  DOI：

文献信息

• Synthesis and Biological Evaluation of Arylthiourea Derivatives with Antitubercular Activity
  作者：Rusong Luo、Tuomo Laitinen、Liyan Teng、Tapio Nevalainen、Maija Lahtela-Kakkonen、Baofu Zheng、Honghai Wang、Antti Poso、Xuelian Zhang

  DOI：10.2174/1570180811310070012

  日期：2013.6.1

  Tuberculosis (TB) is a contagious disease caused by Mycobacterium tuberculosis (M. tuberculosis), and remains one of the most life-threatening plagues for public health in the world. The emergence of drug resistant strains of TB and co-infection with HIV has further complicated TB treatment. Here, the synthesis and characterizaton of a series of compounds were described, and these were followed by evaluating for their antibacterial activity against M. tuberculosis. Several novel arylthiourea derivatives exhibited excellent activity (lowest MIC=0.09 μg/ml) against M. tuberculosis including drug resistant strains of M. tuberculosis. The results suggest that these compounds are promising candidates for new anti-TB agent development.

  结核病（TB）是一种由结核分枝杆菌（M. tuberculosis）引起的传染性疾病，仍然是全球公共卫生的最致命威胁之一。耐药TB菌株的出现以及与HIV的共同感染进一步复杂化了结核病的治疗。本文描述了一系列化合物的合成与表征，随后对其抗菌活性进行了评估，特别是针对结核分枝杆菌。几种新型芳基硫脲衍生物显示出卓越的活性（最低MIC=0.09 μg/ml），能有效对抗包括耐药菌株在内的结核分枝杆菌。这些结果表明，这些化合物是有希望的新型抗结核药物开发候选者。
• Synthesis of Isothiocyanates and Unsymmetrical Thioureas with the Bench-Stable Solid Reagent (Me₄N)SCF₃
  作者：Thomas Scattolin、Alexander Klein、Franziska Schoenebeck

  DOI：10.1021/acs.orglett.7b00689

  日期：2017.4.7

  selective, and rapid transformation of primary amines and diamines to isothiocyanates and cyclic thioureas is disclosed. As opposed to established approaches that employ toxic or volatile electrophilic liquids and require reaction control (i.e., slow addition, cooling), this protocol utilizes the bench-stable, solid reagent (Me4N)SCF3 at room temperature. The method is characterized by operational simplicity

  公开了伯胺和二胺高效，选择性和快速转化为异硫氰酸酯和环状硫脲的方法。与采用有毒或挥发性亲电子液体并需要反应控制（即，缓慢添加，冷却）的既定方法相反，该协议在室温下利用了台式稳定的固体试剂（Me 4 N）SCF 3。该方法的特点是操作简单，速度快，效率高，官能团耐受性高和后期适用性强。副产物为固体，允许通过过滤分离目标化合物。
• Reaction of Thiocarbonyl Fluoride Generated from Difluorocarbene with Amines
  作者：Jiao Yu、Jin-Hong Lin、Ji-Chang Xiao

  DOI：10.1002/anie.201710186

  日期：2017.12.22

  The reaction of thiocarbonyl fluoride, generated from difluorocarbene, with various amines under mild conditions is described. Secondary amines, primary amines, and o‐phenylenediamines are converted to thiocarbamoyl fluorides, isothiocyanates, and difluoromethylthiolated heterocycles, respectively. Thiocarbamoyl fluorides were further transformed into trifluoromethylated amines by using a one‐pot process

  描述了在温和条件下由二氟卡宾生成的硫代羰基氟化物与各种胺的反应。仲胺，伯胺和邻苯二胺分别转化为硫代氨基甲酰氟，异硫氰酸酯和二氟甲基硫代杂环。硫氨甲酰氟通过一锅法进一步转化为三氟甲基化胺。硫代羰基氟化物在原位生成，并在温和条件下在一锅中迅速完全转化；因此，不需要特殊的安全预防措施。
• [EN] GLYT2 MODULATORS<br/>[FR] MODULATEURS DU GLYT2
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2005044810A1

  公开（公告）日：2005-05-19

  α-, β-, and Ϝ-amino acid derivatives of formula I are disclosed as selective GlyT2 inhibitors for the treatment of central nervous system (CNS) conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain. Formula I

  公式I的α-, β-, 和 Ϝ-氨基酸衍生物被披露为选择性GlyT2抑制剂，用于治疗中枢神经系统（CNS）疾病，如肌肉痉挛、耳鸣、癫痫和神经痛。
• Structural Optimization and Structure–Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase
  作者：Fanxun Zeng、Lina Quan、Guantian Yang、Tiantian Qi、Letian Zhang、Shiliang Li、Honglin Li、Lili Zhu、Xiaoyong Xu

  DOI：10.3390/molecules24152780

  日期：——

  and anti-leukemic drugs. The development of promising hDHODH inhibitors is in high demand. Based on the unique binding mode of our previous reported 4-thiazolidinone derivatives, via molecular docking method, three new series 4-thiazolidinone derivatives were designed and synthesized as hDHODH inhibitors. The preliminary structure–activity relationship was investigated. Compound 9 of biphenyl series

  人类二氢乳清酸脱氢酶（hDHODH）是开发免疫抑制药物的有吸引力的靶标之一，也是抗癌药物和抗白血病药物的潜在靶标。开发有前景的 hDHODH 抑制剂的需求量很大。基于我们之前报道的4-噻唑烷酮衍生物的独特结合模式，通过分子对接方法，设计并合成了三个新系列的4-噻唑烷酮衍生物作为hDHODH抑制剂。研究了初步的构效关系。联苯系列化合物9和酰胺系列化合物37的IC50值分别为1.32 μM和1.45 μM。该研究将为hDHODH抑制剂新结构的研究提供有价值的参考。